ArticleAging clinical and experimental research2026
Refining risk prediction in geriatric heart failure: the emergency heart failure mortality risk grade‑BI model under scrutiny.
Article in Aging clinical and experimental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Risk stratification is critical for managing acute heart failure in older adults, yet existing tools often underperform in geriatric populations. Özdemir recently introduced the EHMRG‑BI model, integrating brain natriuretic peptide and endotracheal intubation with the Emergency Heart Failure Mortality Risk Grade score to improve 30‑day mortality prediction. While the model demonstrates improved discrimination in a single‑center derivation cohort, several methodological considerations warrant attention. The inclusion of intubation, a treatment decision rather than a baseline characteristic, may introduce bias and limit its utility as an arrival‑time tool. The absence of key geriatric domains such as frailty, functional status, and cognitive impairment may result in residual confounding. Additionally, modelling BNP as a linear predictor disregards its well‑documented non‑linear association with mortality. This Matters Arising offers a perspective on these challenges and proposes refinements, including external validation, integration of geriatric assessments, and flexible BNP modelling, to strengthen the model's clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.